NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Finnrick
Free Test
← KLOW vendors

NexaphKLOW

2 testslatest 4 Jun 2026$5.72/mg median
Visit websitenexaph.comIntelligence report31 pages · who runs this vendorMonitor this vendor24/7 safety alerts · Finnrick Gold
Peptide testing

Ordered KLOW from Nexaph? Mail in a sample (US only) and let us test it.

Test my supply
+7 more ↓
69%
Finnrick rating
#4 of 9 KLOW vendors
2 of 2 classifiable tests passed
natural 100% · customers 4.7★ (4)
methodology · Purity focus
Finnrick analysis · KLOW

Nexaph's strongest purity-focus evidence is in GHK-Cu, with Retatrutide and Tirzepatide improving recently after earlier purity and fill outliers. The record is dispersed: Semaglutide, Tesamorelin, and CJC-1295 remain weak from repeated purity or identity/quantity failures, and batch-ID gaps temper an otherwise current, high-volume dataset.

methodology →
vendor intelligence report
Vendor Intelligence Report: Nexaph

Corporate records, RDAP data and site emails trace Nexaph through a fragmented operator identity rather than a clean public counterparty. The report maps sister-brand infrastructure, COA-cloning pathways and a certification/payment layer that changes buyer recourse.

31 pages8 risk factors assessed3 Jul 2026
read the report
Peptides
16 rated · tap to focus
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.25
89%
12
2
Tirzepatide
$1.13
76%
62
3
Retatrutide
$2.46
74%
104
4
PT-141
-
72%
3
5
KLOWselected
$5.72
69%
2
6
BPC-157
$1.52
62%
20
7
Ipamorelin
$1.30
60%
10
8
Cagrilintide
$3.50
51%
13
9
TB-500
$1.61
39%
6
10
Tesamorelin
$2.88
37%
30
11
Sermorelin
-
36%
3
12
CJC-IPA
$3.96
36%
1
13
CJC-1295
$3.40
35%
9
14
Semaglutide
$1.90
35%
15
15
MOTS-c
$1.88
30%
6
16
NAD+
$0.04
26%
3
Contact channels
2 channels on file
Websitenexaph.comEmailcain@nexaph.com
Rating trend
KLOW from this vendor, after each test
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%1 Jun 2026: 53%4 Jun 2026: 65%23 Oct 2026: current 69%53%69%Jun 26Oct 26
Showing KLOW tests only
Nexaph KLOW test history
2 tests · 2 pass · 0 fail
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
4 Jun 2026Pass
esafh6u
Tested
lab nameView COA
1 Jun 2026Pass
dbnqtvu
Tested
lab nameView COA

About Nexaph test results from Finnrick

Nexaph is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 16 peptides and 299 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Nexaph peptides in this dataset are BPC-157 (20 tests) and Semaglutide (15 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests.

Corrections
0 corrections
No corrections.
Peptide testing

Ordered KLOW from Nexaph? Mail in a sample (US only) and let us test it.

Test my supply